Oncothermia

First, Oncothermia is an adjuvant treatment against cancer.

Oncothermia treatment promotes a natural regulatory process in the body. Also, It inhibits the natural activity of malignant cells.

And, Oncothermia is indicated for: primary tumours, brain tumours, gynaecological tumours, metastases, lymphomas and melanomas.

It is a non-invasive method. It has hardly any contraindications.

Tag Archive for: Oncothermia

Ascending colon cancer treated with Oncothermia and Chemotherapy

The following is the clinical case of a 63-year-old male patient. The diagnosis is ascending colon cancer with liver metastases. He was treated with chemotherapy, combined with oncothermia.

Diagnosis

In November 2016, he presented with an ascending colon neoplasm. Consequently, he underwent a right hemicolectomy. As a result, the biopsy showed infiltrating adenocarcinoma.

Subsequently, in January 2017, she presented with elevated CEA. A CT scan revealed mesenteric and retroperitoneal lymphadenopathy. Multiple liver metastases were also observed, the largest measuring 35 mm.

Treatment

Immediately, in February 2017, he started treatment with chemotherapy (FOLFOX) and 4 sessions of 90-minute oncothermia.

The CT scan of April 2017 showed resolution of the mesenteric and retroperitoneal adenopathies. There was also a significant decrease in the multiple liver metastases, the largest being 14 mm.

Result

Finally a normalisation of tumour markers is detected.


If you wish, you can find more information about colon cancer treated with Oncothermia on our website at this link.

Breast Cancer treated with Chemotherapy and Oncothermia

The following is the clinical case of a 51 year old female patient. The diagnosis is infiltrating ductal carcinoma of the left breast. She was treated with chemotherapy, combined with oncothermia.

Diagnosis

She presented in May 2016 with breast cancer, infiltrating ductal carcinoma of the left breast. Consequently, the MRI shows multiple and extensive irregular confluent foci. In addition, the cancer forms a mass measuring 79 mm x 52 mm x 58 mm extending to the nipple-areola complex with infiltration of the dermis.

Treatment

In June 2016 she started chemotherapy with Paclitaxel and Trastuzumab. Subsequently, in August 2016, oncothermia treatment was started, with 60-minute sessions.

Result

In October 2016 a breast MRI is performed for control, after the administration of 9 sessions of chemotherapy and 6 sessions of 60-minute oncothermia.

The result of the MRI shows disappearance of the tumour mass indicating a complete response to treatment.

Consequently, the patient refuses surgical treatment as there is no tumour mass and continues with radiological controls. In October 2018 the patient has shown no signs of recurrence.


If you wish, you can find more information about breast cancer treated with Oncothermia on our website at this link.

Pancreatic Cancer treated with Oncothermia, Chemotherapy and Radiotherapy

The following is a case report of a 72 year old female patient. The diagnosis is pancreatic cancer. She was treated with chemotherapy and radiotherapy, combined with oncothermia.

Diagnosis

She presented in March 2017 with a 4 cm tumour in the neck of the pancreas. In particular, the biopsy shows adenocarcinoma.

Treatment

He could not be resected surgically and started chemotherapy with Folfirinox together with 10 sessions of 90 minutes of Oncothermia.

Subsequently, in July 2017, a control CT scan was performed, showing a tumour reduction of 50%. He then started treatment with radiotherapy plus 10 sessions of 90-minute oncothermia.

Result

A new CT scan in June 2018 showed tumour stability with Ca 19-9 CEA tumour markers within normal limits.


If you wish, you can find more information about pancreatic cancer treated with Oncothermia on our website at this link.

Rectal Cancer treated with Oncothermia and Surgery

The following is a case report of a 67 year old male patient. The diagnosis is rectal cancer. He was treated with oncothermia and surgery.

Diagnosis

He presented with rectal adenocarcinoma in February 2018. In particular, it is a tumour 6 cm from the anal margin occupying one third of the intestinal lumen. In addition, the ultrasound scan showed serosal involvement, and it was classified as stage III.

Treatment

Preoperative chemotherapy and radiotherapy are recommended to reduce the tumour volume and perform surgical resection.

In this case, the patient categorically rejects chemotherapy and radiotherapy. On the contrary, he decided to start treatment with Oncothermia, with the aim of reducing the tumour volume and undergoing surgery.

He underwent 20 sessions of 90-minute oncothermia for 2 months, with a frequency of 3 sessions per week.

Result

Ultrasound endoscopy in May 2018 showed a T1 polypoid lesion. In September 2018 he underwent endoanal resection of the polypoid lesion with all the margins of the piece free of tumour.


If you wish, you can find more information about rectal cancer treated with Oncothermia on our website at this link.